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ABSTRACT  Human plasma fibronectin  bound to confluent cell layers of cultured  human-skin 
fibroblasts  in  two  distinct  pools.  Initial  binding  of fibronectin  occurred  in  a  deoxycholate- 
soluble  pool  (Pool  I).  Binding  in  Pool  I was reversible  and  reached a steady state after 3  h. 
After  longer  periods  of  incubation,  fibronectin  became  bound  in  a  deoxycholate-insoluble 
pool (Pool II). Binding in Pool II was irreversible and proceeded at a linear rate for 30 h. After 
30 h  of  incubation,  a significant  proportion  of fibronectin  bound  in  Pool  II  was  present as 
disulfide-bonded multimers.  HT1080 cells, a human sarcoma cell line, did not bind fibronectin 
in either pool. Also, isolated cell matrices prepared by deoxycholate extraction did not bind 
fibronection.  Binding  of  fibronectin  in  Pool  I  of  normal  fibroblasts  occurred  via  specific, 
saturable receptors.  There were  128,000 binding sites  per cell,  and  KD~ss  was 3.6 X  10  -8 M. 
Fluorescence microscopic localization of fibronectin bound in Pool I and Pool II was performed 
using  fluorescein-conjugated  fibronectin.  Fluorescent  staining  in  Pool  I  was  present  in  a 
punctate pattern and in short, fine fibrils. Pool II fluorescence was exclusively in coarse, dense 
fibrils.  These data indicate that plasma fibronectin  may  become incorporated  into the tissue 
extracellular matrix via specific cell-surface receptors. 
Fibronectin  is a  large molecular weight glycoprotein that is 
found in most tissues and body fluids.  The fibronectins that 
have been most extensively studied are the fibronectin syn- 
thesized by cultured cells and the fibronectin isolated from 
plasma (reviewed in  19,  31,  40).  Both types of fibronectins 
are 400-500-kdalton disulfide-bonded dimers of similar 200- 
250-kilodalton subunits. Although both fibronectins have spe- 
cific binding sites for collagens, fibrin, hyaluronic acid, hep- 
arin, staphylococci, and actin, differences between them have 
been detected  for some structural  (12),  immunological (3), 
and biological (46) properties. 
Cellular fibronectin exists as an insoluble connective tissue 
protein found on cell surfaces and in the extracellular matrix 
where it may function as an adhesive protein for cell attach- 
ment and tissue organization. The fibronectin synthesized in 
cell culture is found both in the culture medium and deposited 
in the cell  layer where it forms disulfide-bonded multimers 
(4, 6, 20, 2 l, 27). The cell surface and extracellular fibronectin 
is found  in close association with  collagen, heparan sulfate 
proteoglycans, hyaluronic acid, and other proteins making up 
a detergent-insoluble extracellular matrix (4,  5,  15,  17,  18). 
Transformed cells lack a prominent fibronectin matrix, which 
may result from decreased synthesis (7) and/or deposition of 
fibronectin (13) into the cell layer. 
Although fibronectin is present in a soluble form at levels 
of 300  #g/ml  in  human  plasma,  the  function  of plasma 
fibronectin is uncertain.  Plasma fibronectin becomes incor- 
porated into the clot during coagulation where it may serve a 
role in  wound  healing as an attachment site for cells  (11). 
Recently,  in  vivo experiments have  indicated  that  plasma 
fibronectin can be incorporated into tissue extracellular mat- 
rices,  suggesting that plasma fibronectin may serve as a  res- 
ervoir for tissue fibronectin (33).  This theory is supported in 
vitro with the observation that serum fibronectin from serum- 
supplemented cell  culture  medium is incorporated into the 
cell layer (14,  39). 
The present study characterizes the binding and incorpo- 
ration of plasma fibronectin to cell layers of cultured human 
fibroblasts. The data indicate that soluble fibronectin is ini- 
tially bound to cell surface receptors that mediate the assembly 
of fibronectin into the multimeric, insoluble matrices char- 
acteristic of connective tissue. 
MATERIALS  AND  METHODS 
Cell Culture:  Human embryonic skin cells were of locally established 
strains (Dr.  Catherine Reznikoff, University of Wisconsin) and cultured in 
Ham's F-12 nutrient medium (Gibco Laboratories, Grand Island, NY) supple- 
mented with  10% fetal  calf serum (Sterile  Systems, Logan, UT),  100 U/ml 
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were customarily split 1:4 every 7 d. All experiments were performed between 
passages 4 and 15 and I-3 d after the cells reached confluence. Cell layers were 
trypsinized, and cell counts were done in a hemocytometer.  HT-1080 human 
sarcoma cells (38) were a gift from Dr. Leo Furcht,  University of Minnesota. 
HT-1080  cells were grown in  Dulbecco's  modified  Eagle's medium (Gibeo 
Laboratories)  supplemented  with  10% fetal calf serum containing  the above 
antibiotics. 
~2Sl-fibronectin was given  to cell cultures  in  Ham's F-12  or Dulbecco's 
modified Eagle's medium (HT-1080 cells) supplemented with 10% fibronectin- 
depleted human serum. Human serum was depleted of fibronectin by treating 
a unit of fresh frozen plasma (Badger Red Cross, Madison, WI) with thrombin 
(Parke-Davis,  Morris  Plains,  N  J)  and  calcium  chloride  at  4"C  (29). Final 
concentrations  of thrombin  and  calcium  ion  were  2  U/ml  and  40  mM, 
respectively. Clots were removed after 4 h. Because platelets do not release at 
4"C, serum was supplemented  with platelet releasate prepared by thrombin (3 
U/ml final concentration)  activation of I U of unwashed fresh human platelets 
(Badger Red Cross). Fibronectin  concentration  of the serum was l0 #g/ml as 
determined  by a competitive  radioimmunoassay  (41). The serum fibronectin 
appeared  intact  after purification  on gelatin-sepharose and electrophoresis on 
polyacrylamide  gels. Thus, the concentration  of fibronectin  in medium con- 
taining  10% serum was l #g/ml. To quantify fibronectin binding to cell layers, 
it was assumed that the iodinated plasma fibronectin could bind as well as the 
serum flbronectin, lodination  of the molecule was judged to have no effect on 
binding since a constant  proportion of labeled fibronectin bound to cell layers 
over a wide range of ratios of labeled to unlabeled protein. 
Purification  of Human  Plasma Fibronectin:  Human  plasma 
fibronectin was purified from a fibronectin and fibronogen-rich by-product  of 
Factor VIII production  (32). The plasma fraction was dissolved in 0.01 M Tris 
and 0.4 M sodium chloride, pH 7.4. Fibrinogen was precipitated by heating at 
56"C for 3 rain.  The solution  was clarified by centfifugation  and chromato- 
graphed on DEAE-cellulose. The fibronectin  peak from the column was pre- 
cipitated with ammonium sulfate, dialyzed against Tris-buffered saline (TBS)  ~, 
and frozen at -70* until used. 
lodination of Fibronectin:  Purified plasma fibronectin (400 #g) was 
iodinated with 1 mCi Na~2Sl (New England Nuclear, Boston, MA) using 50 #g 
of chloramine  T in 0.04 M phosphate buffer, pH 7.4. After 60 s, 5 mg of BSA 
was added to the reaction  mixture, and iodinated  fibronectin  was purified on 
gelatin-Sepharose,  dialyzed  against  TBS, and frozen  at -70*  until  use. The 
specific activity  of ~2Sl-fibronectin was 250  #Ci/mg.  Integrity  of the labeled 
protein  was assessed by polyacrylamidle gel electrophoresis in SDS with and 
without reduction. 
Binding of ~251-Fibronectin to Cultured Cells:  All bindingwas 
done in  F-12 or Dulbecco's  modified  Eagle's medium and  10% fibronectin- 
depleted human serum containing 250,000-800,000  cpm of t2sI-fibronectin per 
ml. After incubation  with labeled medium at 37"C, cultures were rinsed three 
times  in  Hanks' balanced  salt solution  (HBSS), and  cell layers were either 
sequentially extracted in  1% deoxycholate followed by 4% SDS or directly in 
4% SDS. Deoxycholate extractions were done in a 0.02 M Tris (pH 8.3) buffer 
containing  2  mM  phenylmethylsulfonilfluoride,  2  mM  ethylene  diamine 
tetraacetic acid, 2 mM ethylmaleimide, and 2 mM iodoacetic acid. For sequen- 
tial extractions, cell layers were scraped into 1% deoxycholate and centrifuged 
at 17,000 rpm for 20 min. Deoxycholate-insoluble material was solubilized at 
70"C in 4% SDS. 
Isolated cell matrices were obtained by extracting confluent cell layers with 
1% deoxycholate containing the above inhibitors. Extractions were carried out 
for 10 min at room temperature.  Matrices were then rinsed several times with 
HBSS prior to incubation  with ~25I-fibronectin. 
Cell  Attachment  Assay:  For attachment  of cells to  fibronectin- 
coated substrata (10), plastic tissue culture plates (Bellco Glass, Inc., Vineland, 
NJ) were incubated  for 1 h at room temperature  in TBS containing  10 ~g/ml 
purified  plasma  fibronectin  or  BSA. This  was  followed  by  a  second  l-h 
incubation  at room temperature  in 0.2% BSA in TBS. The plates were then 
rinsed 3 times with TBS and incubated with human fibroblast cells (I .2 x  l0  s 
cells/ml) or HT 1080 sarcoma cells (1.5 ×  l0  s cells/ml) in Dulbecco's modified 
Eagle's medium for 1 h at 37"C. Plates were then shaken on a linear shaker 
(180 strokes/min)  for 1 min, the medium was removed,  and the plates were 
rinsed  3 times with  TBS. For visualization  and counting,  the attached  cells 
were fixed with  3% formaldehyde  for  10  min and  stained  with  Coomassie 
Brilliant Blue. 
Gel  Electrophoresis:  SDS  PAGE  was  performed  on  slabs  of 8% 
separating  and  3.3% stacking gels using a  discontinuous  buffer  system (25). 
Marker proteins were visualized by staining with Coomassie Brilliant Blue. For 
~Abbreviations used  in  this  paper.  HBSS,  Hanks'  balanced  salt 
solution; TBS, Tris-buffered saline. 
visualizing ~2sI-fibronectin,  slabs were dried and autoradiographed  with Kodak 
X-Omat R Xray film. All materials for electrophoresis were obtained from Bio- 
Rad Laboratories (Richmond,  CA). 
Incorporation of Fluoresceinated Fibronectin  into Cell Cul- 
tures:  Fibronectin (2 mg/ml) was dialyzed against 4 mM carbonate buffer, 
pH 9.5, containing  0.15 M NaCl. Fluorescein isothiocyanate (Cappel Labora- 
tories, Cochranville, PA), 500 #g in  l ml of carbonate  buffer, was added to a 
final concentration  of l0 ug/ml.  The fibronectin-fluorescein solution  was left 
for l h at room temperature  with constant stirring. Fluoresceinated fibronectin 
was separated from free fluorescein by chromatography  on Sephadex G-25 in 
PBS, pH 7.4. The ratio ofA 49s"m to A  28°"~ was 0.6. BSA was labeled by the 
same procedure. 
Early binding of fluoresceinated fibronectin in Pool I was done on confluent 
cultures  of human embryonic  skin cells grown on glass coverslips. Cultures 
were rinsed twice with  HBSS and incubated  with 200 #g/ml fluoresceinated 
fibronectin  in  F-12  supplemented  with  10%  human serum (fibronectin-de- 
pleted). After 15 min, medium was removed, cell layers were rinsed three times, 
and coverslips were processed for fluorescent photography.  Pool II was labeled 
by incubation of  confluent cell layers with 100 #g/ml fluoresceinated fibronectin 
in F-12 containing  10% fetal calf serum. After 3 h, the medium was replaced 
with unlabeled medium, and cultures were incubated for an additional  24 h. 
Coverslips containing  fluoresceinated fibronectin in either Pool I or Pool II 
were rinsed twice with HBSS, fixed with 3.5% paraformaldehyde  for 30 rain, 
rinsed, mounted on glass slides in 50% glycerine-PBS, and photographed  on a 
Zeiss microscope equipped  with epifiuorescence and phase contrast.  Control 
experiments were done using fluoresceinated BSA. 
RESULTS 
Time Course of Binding 
Before characterizing the binding of ~251-flbronectin to cell 
layers, an experiment was done to determine the number of 
rinses necessary to distinguish bound radioactivity. Cultures 
were incubated with '2sI-fibronectin for l0 min, medium was 
removed, and cell layers were rinsed sequentially with HBSS. 
Radioactivity in both the rinse and the cell layer was deter- 
mined. Fig.  l indicates that after three rinses, the radioactivity 
bound  in  the  cell  layer remained  constant.  Cultures  were 
therefore washed three times prior to analyzing bound radio- 
activity. 
Fig.  2a represents a  2-h time course of iodinated human 
plasma fibronectin bound to confluent cell layers of cultured 
human skin fibroblasts. Bound '25I-fibronectin became asso- 
ciated with the cell layer in two distinct pools. Initial (2-10 
min) binding of '2sI-fibronectin to the cell layer occurred in a 
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FIGURE  1  Sequential  rinsings 
of cell layers containing bound 
1251-fibronectin. Confluent cul- 
tures  were  incubated  with  1 
ml of medium containing 12Sl- 
fibronectin (950,000 cpm/ml) 
for  10  rain.  Medium  was  re- 
moved,  and  cell  layers  were 
rinsed with  1 ml of HBSS.  Ra- 
dioactivity was determined in 
rinses (Q) and cell layers after 
each rinse (O).  Cultures were 
in  9.6-cm 2 dishes  containing 
5.8 x  10  s cells each. 
MCKEOWN-LONGO AND MOSHER  Binding  of Plasma Fibronectin  467 bation, a portion of the bound fibronectin became deoxycho- 
late insoluble (Pool II). Fibronectin bound in Pool II could 
be solubilized in 4% SDS.  Binding in Pool I reached apparent 
equilibrium  in  3  h  (Fig.  2b).  Binding  of ~25I-fibronectin in 
Pool  II  approached  a  steady  state  after  30  h  in  culture. 
Degradation of J25I-fibronectin  by the cell cultures was mon- 
itored by the appearance in the culture medium of radioactiv- 
ity in a  10% trichloroacetic acid-soluble form. After 30 h  in 
culture, only 1.0% of the added '25I-fibronectin was in a form 
that  was  soluble  in  10%  trichloroacetic  acid.  In  addition, 
electrophoresis in  SDS  of cell  culture  medium  showed  no 
breakdown products of ~25I-fibronectin (data not shown). The 
distribution of bound 125I-fibronectin in both Pool I and Pool 
II over the 30-h time course is plotted in Fig. 2 c. >90% of the 
bound  '25I-fibronectin was in  Pool I at early binding times. 
After 30 h, 70% of the bound ~25I-fibronectin was present in 
Pool II. 
Extracts containing bound ~25I-fibronectin from Pool I and 
Pool II were characterized by polyacrylamide gel electropho- 
resis in SDS with and without reduction (Fig. 3). The material 
from Pool I migrated as fibronectin monomer after reduction 
(200  kdaltons) or fibronectin dimer without reduction (400 
kdaltons). '25I-fibronectin from Pool II migrated as fibronectin 
monomer  upon  reduction.  Unreduced  samples,  however, 
contained  a  proportion  of disulfde-bonded  aggregates that 
remained at the  top of the  stacking gel.  The proportion  of 
~25I-fibronectin  in  these  aggregates  increased  over time  in 
culture. In addition, there was a small amount of radioactivity 
that penetrated the separating gel, but migrated more slowly 
than dimeric fibronectin. This material was not present in the 
samples from  Pool  I.  '25I-fibronectin extracted  from either 
pool  was  intact  at  all  time  points,  e.g.,  material  of <200 
kdaltons  or  400  kdaltons  was  not  observed when  samples 
were analyzed with or without reduction. 
Reversibility  of Binding 
Reversibility of binding in Pool I was tested by incubating 
confluent cultures with  '25I-fibronectin for 30 min, washing 
three  times,  and  chasing bound  radioactivity from the  cell 
layer with  HBSS  or  HBSS  supplemented  with  100  ug/ml 
unlabeled  fibronectin (Fig.  4).  After 3 h  of incubation with 
excess  fibronectin,  70%  of the  bound  '25I-fibronectin was 
displaced from the cell layers. The rate of displacement was 
slightly greater when fibronectin was included in the buffer. 
Reversibility of binding in  Pool II was also tested. Cultures 
were incubated with '25I-fibronectin for 3 h, labeled medium 
was  removed,  and  cultures  were  washed  three  times  and 
incubated with medium containing 10% fibronectin-poor hu- 
man serum (1  ug/ml fibronectin) or medium supplemented 
with  serum  and  100  ug/ml  fibronectin.  The  cultures  were 
processed at  designated  times to  determine  '25I-fibronectin 
remaining in each pool (Fig.  5). The bound radioactivity in 
Pool I steadily decreased and after 22 h,  no detectable radio- 
activity remained.  The rate  of loss of '25I-fibronectin from 
Pool I in  medium containing  100  ug/ml of fibronectin was 
identical  to  the  rate  of loss  in  the  presence of  1 ug/ml  of 
fibronectin. After 28 h of chase, 92% of the labeled fibronectin 
FIGURE 3  Polyacrylamide slab gel electrophoresis of ~2Sl-fibronec- 
tin bound in Pool I and  Pool II. Shown are autoradiograms  of gels 
of bound  ~2Sl-fibronectin extracted from  cell layers at  the times 
designated  in  the figure.  Samples from each pool were analyzed 
with and without reduction with 2-mercaptoethanol (BME)  as indi- 
cated. The arrows  indicate the top of the stacking gel, the top of 
the separating gel, dimeric fibronectin standard,  and  monomeric 
fibronectin standard. 
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FIGUre  2  Time course of binding of human  plasma fibronectin  to cell layers. Cultures were incubated with 2  ml of medium 
containing 'zsl-fibronectin (250,000 cpm/ml) for 2 h (a) or 1251-fibronectin  (150,000 cpm/ml) for 30 h (b). At the indicated times, 
the cell layers were sequentially extracted to determine T2Sl-fibronectin  in  Pool  I (O) or Pool II  (A). Total bound  ~251-fibronectin 
(O) is also plotted. Degradation of ~2Sl-fibronectin  was monitored by the appearance of radioactivity soluble in 10% trichloroacetic 
acid (x). Nonspecific binding of ~2Sl-fibronectin  to plastic tissue culture plates ranged from 14 to 38 ng over the 30-h period. ~2Sl- 
fibronectin  bound  to  the  cell  layer at  30  h  represents 20%  of the added  radioactivity. Studies were done  in  28-cm  2 dishes 
containing 2.0  x  106 cells, and data are expressed as nanograms fibronectin  (FN) bound  per dish. The data from  Fig. 2b were 
plotted to show the distribution of bound l~Sl-fibronectin in Pool I (O) and Pool II (A) (c). 
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FIGURE 4  Reversibility  of ~2Sl- 
fibronectin  binding  in  Pool  I. 
Cell  layers  were  incubated 
with 2 ml of medium contain- 
ing  '251-fibronectin  (450,000 
cpm/ml) for 30 min. The me- 
dium was then replaced with 
HBSS with (@) and without (O) 
unlabeled fibronectin (100 #g/ 
ml).  At  the  designated  time 
points, cell layers were rinsed, 
and scraped into 4% SDS, and 
radioactivity  was determined. 
Cultures  were  in  28-cm 2 
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FIGURE 5  Irreversibility  of 
12Sl-fibronectin binding in Pool 
II. Cell layers were  incubated 
with 2 ml of medium contain- 
ing  12Sl-fibronectin  (450,000 
cpm/ml)  for  3  h  resulting  in 
60%  (107  ng)  of  the  bound 
USl-fibronectin  in  Pool  I  and 
40% (73 ng) in Pool II. Labeled 
medium was removed and re- 
placed with  medium contain- 
ing  10%  human  serum  with 
either 1 ~tg/ml (- -) or 100 #g/ 
ml  (  )  unlabeled fibronec- 
tin.  At  the  designated  time 
points, cell layers were processed for determinations of radioactivity 
in Pool I (@, O) and Pool II (,t, A). Cultures were in 28-cm 2 dishes 
containing 2.9 x  106 cells each. Data are expressed as nanograms 
fibronectin bound per dish. 
in the medium was in a form that was precipitable with  10% 
trichloroacetic acid (data not shown), suggesting that the '251- 
fibronectin  was  being  displaced  intact  and  not  degraded. 
There was no net loss of fibronectin from Pool II over the 28- 
h  time  course studied.  In fact,  there was an increase in the 
radioactivity  in  Pool  II  that  was  evident  at  all  time  points 
after 60 min of chase. This increase was most marked in those 
cultures chased with fibronectin-depleted serum containing  1 
#g/ml  of  fibronectin.  Cultures  chased  with  serum  supple- 
mented with  100 ug/ml fibronectin showed a smaller increase 
in bound '25I-fibronectin in Pool II. 
was determined in Pool I and Pool II. HT  1080 cells neither 
bound nor accumulated fibronectin in either Pool. 
Both  cell  types  were  also  compared  in  a  standard  cell 
attachment  assay in which  cells in  suspension were allowed 
to attach and spread on plastic tissue culture plates containing 
adsorbed fibronectin.  HT  1080 cells, as well as normal cells, 
attached and spread on fibronectin-coated plates. After one h 
of incubation on fibronectin-coated culture dishes, 23% of the 
HT  1080  and  17%  of the  fibroblast  cells  were  specifically 
attached. 
Saturation of Binding 
Cell  layers were incubated  with  increasing concentrations 
of  ]25I-fibronectin  without  or  with  an  excess  of unlabeled 
fibronectin. Total, nonspecific and specific binding are shown 
in Fig.  7A.  Specific  binding became saturated with  ~40  ng 
of fibronectin  per dish or  100,000  fibronectin  molecules per 
cell. Half-saturation occurred when fibronectin concentration 
was 8  #g/ml  or 2  x  10 -8  M.  These data were also analyzed 
according to the method of Scatchard (42), and a straight line 
(r -- -0.96) was fitted by linear regression (Fig. 7B). The line 
crosses  the  abscissa  at  l l.8  pmol,  which  corresponds  to 
128,000 binding sites per cell.  The dissociation constant cal- 
culated from the slope of the line is 3.6 x  l0 -8 M. 
Labeling of Pool I and Pool II with 
Fluoresceinated Fibronectin 
To localize where in the cell-layer fibronectin binds in Pool 
I and Pool II, cell layers were incubated with fluoresceinated 
fibronectin.  Pool  !  was labeled by incubating  confluent  cell 
layers with fluoresceinated fibronectin for 20 min. Pool II was 
TABLE  I 
125  Binding of  I-Fibronectin  to Intact and Deoxycholate- 
extracted Cell Layers 
0.5h  1 h  3h  6h  24h  30h 
Cell layer  14  37  98  135  233  248 
Matrix  14  17  17  9  3  2 
Isolated cell matrices were prepared by extracting  confluent cell layers with 
1% deoxycholate. Cultures  contained  ~1.5 x  106 cells prior to extractions. 
Values are in nanograms.  Background  binding to blank plastic dishes was ~7 
ng and has been subtracted  from each determination. 
Binding to Isolated Cell Matrices 
A detergent-insoluble extracellular matrix was prepared by  5o 
extracting confluent fibroblast cell layers with  1% deoxycho- 
late. The detergent-insoluble material appeared as a fine mesh- 
40  work (5,  17) containing  fibronectin  and  collagen  when  ex-  = 
amined using indirect immunofluorescence (not shown). The 
matrices  bound  very little  fibronectin  when  compared with  ~  3o 
intact cell layers (Table I). Although some fibronectin bound 
at early times (0.5 h), there was no retention or accumulation,  o  20 
Z 
Binding to Transformed Cells  " 
A human sarcoma cell line, HT 1080, was tested for ability  i o 
to bind '25I-fibronectin over a 30-h time course (Fig. 6). These 
cells were chosen because they are known to synthesize fibro- 
nectin but do not incorporate it into an extracellular matrix 
(1).  Cell  layers of normal  human  fibroblasts  and  HT  1080 
cells  were  incubated  with  '25I-fibronectin  and  radioactivity 
....  ,8  {0 
Hours 
FIGURE 6  Time course of bind- 
ing of human plasma fibronectin 
to normal and transformed cells. 
Confluent  cultures  of  human 
fibroblasts  (4.4  x  10  s  cells/ 
dish) and human sarcoma (HT- 
1080) cells (3.2 x  106 cells/dish) 
were incubated with 2 ml of me- 
dium containing 1251-fibronectin 
(400,000 cpm/ml).  At the  indi- 
cated times, cell layers were se- 
quentially extracted and  radio- 
activity was determined in each 
pool.  The  data are  normalized 
for  cell  number and  expressed 
as  nanograms  fibronectin  ex- 
tracted  from  HT-1080  cells  in 
Pool  I  (A)  and  Pool  II  (A)  and 
from fibroblasts in Pool I (O) and 
Pool II (0). 
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FIGURE  7  Saturation  binding of 12Sl-fibronectin to cell  layers.  In- 
creasing concentrations of ~251-fibronectin  (specific activity 90 #Ci/ 
mg) were incubated in  1 ml of medium with cell layers for 10 min. 
Nonspecific  binding  (O)  was determined  by  adding excess unla- 
beled fibronectin  (500 p,g/ml) to the incubation medium. Specific 
binding (A) was obtained by subtracting nonspecific  binding from 
total binding (0). Values are nanograms fibronectin bound per plate. 
Scatchard analysis (7B) was also performed on these data. Cultures 
were in 9.6-cm  2 dishes containing 5.8 x  105 cells each. 
labeled by incubating cell  layers with  fluoresceinated fibro- 
nectin  for  3  h  and  then  chasing  cell  layers with  complete 
medium  for  24  h.  Based  on  preliminary experiments,  cell 
layers were incubated with appropriate amounts of fluores- 
ceinated fibronectin so that there was equivalent fluorescence 
in Pool I and Pool II. Fig.  8 a  shows that the fluoresceinated 
fibronectin bound in Pool I was present in punctate material 
and short, fine fibrils. All fluorescent material appeared in the 
same plane of focus as the cell layer. The staining in Pool II 
(Fig.  8 b) was exclusively fibrillar with longer, coarser fbrils 
than the Pool I fibrils.  Many of the fibrils in Pool II were in 
a plane of focus above the cell surface. 
DISCUSSION 
Plasma fibronectin bound to and became incorporated into 
cell layers of  cultured human skin fibroblasts. The same results 
were obtained using human embryonic lung fibroblasts, hu- 
FIGURE  8  Binding of fluoresceinated fibronectin to cell  layers. Cell  layers were incubated with  fluoresceinated fibronectin  as 
described in Materials and Methods to specifically label either Pool I (a) or Pool II (b).  Exposures were 30 s. Control cultures with 
incubated fluoresceinated BSA are shown in (c) and (d). Exposures were 40 s. x  400. 
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not shown).  After 24 h,  650  ng of plasma fibronectin were 
bound  into  the  cell  layer  (Fig.  2).  This  agrees  well  with 
previous studies (30), which show that cell layers of  embryonic 
skin flbroblasts accumulate  l  ~g of cellular fibronectin over 
the  same period.  Binding  continued  for hours,  and bound 
fibronectin associated with the cell layer in two separate pools, 
distinguished by solubility in 1% deoxycholate. Initial binding 
of fibronectin to the cell layer was reversible and occurred in 
a form that was soluble in deoxycholate (Pool I). Fibronectin 
that was incubated with the cell  layer for longer periods of 
time became irreversibly bound and was no longer soluble in 
deoxycholate (Pool II). The accumulation rate of fibronectin 
into Pool II gradually diminished and reached a steady state 
usually between 24 and 48  h  (data  not shown).  This most 
likely resulted from a decrease in specific activity of  the labeled 
fibronectin. Embryonic skin fibroblasts have been shown to 
accumulate 2-3 ~g/ml of endogenous cellular fibronectin in 
the culture  medium over a  24-h period (30).  Chase experi- 
ments (Fig.  5) indicated that some of the fibronectin bound 
in  Pool  I  may be  chased  into  Pool  II.  This  suggests  that 
binding may have proceeded stepwise from Pool I-II. This 
proposal is consistant with the observation that J25I-fibronec- 
tin did not bind to isolated matrix prepared by extraction of 
the cell layer with deoxycholate (Table I). 
The  ~25I-fibronectin  bound  in  Pool  II formed  disulfide- 
bonded multimers in a time-dependent manner. Purified 35S- 
labeled fibronectin from fibroblast-conditioned medium has 
also been  shown to bind to cell  layers and  form disulfide- 
bonded  aggregates  (45).  Pulse-chase  studies  of fibronectin 
synthesized  by hamster fibroblasts have  shown  that  newly 
synthesized fibronectin is initially present in a deoxycholate- 
soluble  form,  slowly becomes  deoxycholate-insoluble,  and 
forms disulfide-bonded  aggregates  (6).  The  similarities  be- 
tween the metabolism of exogenously-labeled plasma fibro- 
nectin and that of endogenously labeled cellular fibronectin 
suggest that tissues may have incorporated plasma and locally 
synthesized fibronectins (6) by a similar mechanism. 
The manner by which fibronectin forms disulfide-bonded 
multimers in the cell layer is as yet unclear. Cellular flbronec- 
tin  has been  shown to contain  one or two free sulfhydryls 
(44), and plasma fibronectin has been shown to contain two 
free sulhydryls per subunit (43).  Others (4,  5) have described 
the presence of disulfide-bonded fibronectin multimers in a 
detergent-insoluble matrix of fibroblasts. Therefore it seems 
likely that the disulfide-bonded multimers seen in our study 
were composed solely of fibronectin. However, the possibility 
exists  that  fibronectin  was  bonded  to  other  available free 
sulflaydryls in the cell layer. 
The data from the saturation binding curve indicate that 
fibroblasts in the confluent monolyer had  128,000  receptor 
sites for fibronectin per cell.  The dissociation constant  for 
fibronectin and its receptor was 3.6 x  10  -s M. These numbers 
were derived from Scatchard's analysis (42) and based on the 
assumption  that  initial  reversible binding  to  the  cell  layer 
represents binding  to a  single type of receptor on  the  cell 
surface. The data points on the Scatchard plot represent 80% 
of the binding curve when drawn as suggested by Klotz (24). 
Evidence for saturable cell surface receptors for plasma fibro- 
nectin  on thrombin-stimulated platelets has been presented 
previously (37). These authors reported 120,000  receptors for 
fibronectin per platelet with a  dissociation constant of 3  x 
l0 -7  M.  Inasmuch  as  the  concentration  of fibronectin  in 
culture  fluid  (and presumably in tissues) is  10- to  lO0-fold 
less  than  the  concentration  in  plasma, it seems reasonable 
that the association constant for fibronectin is stronger with 
fibroblasts than with platelets. 
Most studies oh the characterization of potential cell-sur- 
face receptors for fibronectin  have been  done  using  a  cell 
attachment assay. Cultured cells have been shown to attach 
to collagen-coated (22) or plastic substrata (10) via adsorbed 
fibronectin. This assay has recently been employed to localize 
a specific I 1,000-dalton tryptic fragment of fibronectin as the 
cell-attachment  domain  (36).  Experiments  using  chemical 
cross-linkers (2)  have implicated a  47,000-dalton protein as 
the  fibronectin  receptor in  attaching  baby hamster  kidney 
cells. Competitive inhibition data have suggested that ganglio- 
side-like cell-surface molecules may be involved in the binding 
of Chinese  hamster  ovary  cells  to  fibronectin  (23).  Also, 
because ricin-resistant hamster fibroblasts are less  active in 
cell attachment assays, sugar moieties of  cell-surface glycopro- 
teins have also been proposed as possible fibronectin receptors 
(34). The binding of fibronectin to cell monolayers described 
herein probably did not occur via the same receptors that are 
used  for cell  attachment.  HT  1080  cells that did  not bind 
soluble fibronectin (Fig. 6) could attach and spread on fibro- 
nectin  adsorbed  to  plastic  tissue  culture  plates.  Similarly, 
transformed rat kidney cells that have lost the ability to retain 
synthesized fibronectin on their cell surface readily attach and 
spread on fibronectin-coated substrata (13).  Grinnell (9) has 
shown that the receptors that mediate cell attachment of baby 
hamster kidney cells are no longer present when the cells have 
spread on culture dishes.  Therefore, it is probable that the 
receptors that  bind  soluble  fibronectin  represent a  distinct 
class of fibronectin  receptor involved in  matrix  deposition 
rather than  cell  adhesion,  and  it is  this  class that  may be 
altered during transformation. 
Localization within the cell  layer of fibronectin bound in 
Pool  I  and  Pool  II was done  using  fluorescein-conjugated 
fibronectin. Fibronectin bound in Pool II exhibited the typical 
coarse fibrillar pattern seen in previous indirect immunoflu- 
orescent  staining  of these  (unpublished  results)  and  other 
fibroblast cell layers for fibronectin (e.g.,  16). However, the 
material in Pool I was present both in a punctate pattern and 
in short fine fibrils,  which suggests  that the transition from 
Pool I to Pool II may involve the assembly of surface-bound 
fibronectin into large coarse fibrils.  Such  a  mechanism has 
been proposed for the formation of  collagen fibrils (8). Indirect 
immunofluorescence studies of cytochalasin B-treated fibro- 
blasts suggest that centripetal movement of receptor-attached 
fibronectin on the cell surface may promote the formation of 
fibronectin  fibrils  (26).  Our  data  are  compatible with  the 
hypothesis that cell movement arranges fibronectin molecules 
into fibrils.  Our observations suggest  that, in addition, fibril 
formation involved events that rendered fibronectin insoluble 
to extraction with  1% deoxycholate. Experiments using anti- 
bodies specific to the collagen-binding domain of fibronectin 
have indicated that interaction between fibronectin and col- 
lagens may be important in forming the fibrillar component 
of the  extracellular matrix (28).  In experiments using  J25I- 
fibronectin purified from fibroblast conditioned medium, Per- 
kins et al. (35) demonstrated binding of fibronectin to the cell 
layer and suggest that chondroitin sulfate proteoglycans may 
be important in  the interaction of fibronectin with the cell 
layer. Rennard et al. (39) found that adding soluble collagen 
increased the amount of serum fibronectin that became in- 
McKEowN-LoNc;o AND MOSHER  Binding of Plasma fibronectin  471 corporated into cell layers. Thus, the  insolubilization reac- 
tion(s) may  involve interaction of fibronectin with  several 
matrix components. 
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